Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Hogarty

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Plos One|August 12, 2016
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for NeuroblastomaShigeki Yagyu, Tomoko Iehara, Shiro Tanaka, et al.
The Lancet. Child & Adolescent Health|January 30, 2018
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trialPedro A de Alarcon, Katherine K Matthay, Wendy B London, et al.
Cancer Research|November 20, 2002
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13John M Maris, Matthew J Weiss, Yael Mosse, et al.
Cancer Cell|November 17, 2012
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivationGuoliang Qing, Bo Li, Annette Vu, et al.
Journal of the National Cancer Institute|April 30, 2009
Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomasOlesya Chayka, Daisy Corvetta, Michael Dews, et al.
Pediatric Blood & Cancer|November 28, 2018
The challenge of defining "ultra-high-risk" neuroblastomaDaniel A Morgenstern, Rochelle Bagatell, Susan L Cohn, et al.
The American Journal of Surgical Pathology|March 19, 2021
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology GroupAsuka Kawano, Florette K Hazard, Bill Chiu, et al.
Nature Genetics|December 4, 2012
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastomaMark Sausen, Rebecca J Leary, Siân Jones, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Science Signaling|October 5, 2017
Inhibition of the oncogenic fusion protein EWS-FLI1 causes G<sub>2</sub>-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcomaStefan K Zöllner, Saravana P Selvanathan, Garrett T Graham, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Plos One|August 12, 2016
Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for NeuroblastomaShigeki Yagyu, Tomoko Iehara, Shiro Tanaka, et al.
The Lancet. Child & Adolescent Health|January 30, 2018
Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trialPedro A de Alarcon, Katherine K Matthay, Wendy B London, et al.
Cancer Research|November 20, 2002
Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13John M Maris, Matthew J Weiss, Yael Mosse, et al.
Cancer Cell|November 17, 2012
ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivationGuoliang Qing, Bo Li, Annette Vu, et al.
Journal of the National Cancer Institute|April 30, 2009
Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomasOlesya Chayka, Daisy Corvetta, Michael Dews, et al.
Pediatric Blood & Cancer|November 28, 2018
The challenge of defining "ultra-high-risk" neuroblastomaDaniel A Morgenstern, Rochelle Bagatell, Susan L Cohn, et al.
The American Journal of Surgical Pathology|March 19, 2021
Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology GroupAsuka Kawano, Florette K Hazard, Bill Chiu, et al.
Nature Genetics|December 4, 2012
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastomaMark Sausen, Rebecca J Leary, Siân Jones, et al.
Pediatric Blood & Cancer|June 17, 2009
Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COGChizuko Okamatsu, Wendy B London, Arlene Naranjo, et al.
Science Signaling|October 5, 2017
Inhibition of the oncogenic fusion protein EWS-FLI1 causes G<sub>2</sub>-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcomaStefan K Zöllner, Saravana P Selvanathan, Garrett T Graham, et al.
Pageof 11